Alma Levy

Alma Levy is the RA Director at KAMADA, where they provide regulatory strategy planning to support new products and manage submissions with health authorities since 2013. They have extensive experience in regulatory affairs for biological products and have held roles including RA Team Leader at Omrix Biopharmaceuticals and project manager at XTL Biopharmaceuticals. Alma has a strong educational background, holding an MSc in Biotechnology and multiple PhDs in Cell Biology and Histology from Tel Aviv University, as well as postdoctoral work in Physiology and Neuroendocrinology from the University of Kansas Medical Center. They are recognized for their organizational and communication skills, coupled with a deep understanding of FDA, HC, and EMA regulations.